FDA Authorizes Expanded Use for REGEN-COV mAb

The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

Aug 05, 2021 | Guest Author

COVID-19

FDA Authorizes Expanded Use for REGEN-COV mAb

The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

Aug 05, 2021 | Guest Author

3 Newsletters1200 1
Back to Top